All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

• RATE: Reduced anticoagulation targets in extracorporeal life support Pending
  2023-509675-16-01 5

Showing 1–1 of 1 trials